APO RESEARCH · REPORT
Antibody
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Product & engineering
Understand the product.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Selected research
Industry Research
Antibody Industry Research Report 2026
Market perspective
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
Read the full market overview
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
Report Scope
This report quantifies the global Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (KG), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/KG) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antibody Market by Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody Segment by Type
IgM
IgG
IgA
Other
Antibody Segment by Application
Therapeutic
Research
Diagnostic
Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IgM
- IgG
- IgA
- Other
Applications
- Therapeutic
- Research
- Diagnostic
Companies covered
- Roche
- Johnson and Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antibody Market Size (2021-2032)
- 2.2.2 Global Antibody Sales (2021-2032)
- 2.2.3 Global Antibody Market Average Price (2021-2032)
- 2.3 Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 IgM
- 2.3.3 IgG
- 2.3.4 IgA
- 2.3.5 Other
- 2.4 Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Therapeutic
- 2.4.3 Research
- 2.4.4 Diagnostic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antibody Sales (KG) of Manufacturers (2021-2026)
- 3.3 Global Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antibody, Product Type & Application
- 3.8 Global Manufacturers of Antibody, Established Date
- 3.9 Global Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche Antibody Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Johnson and Johnson
- 4.2.1 Johnson and Johnson Company Information
- 4.2.2 Johnson and Johnson Business Overview
- 4.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson and Johnson Antibody Product Portfolio
- 4.2.5 Johnson and Johnson Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Antibody Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Antibody Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 AbbVie
- 4.5.1 AbbVie Company Information
- 4.5.2 AbbVie Business Overview
- 4.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AbbVie Antibody Product Portfolio
- 4.5.5 AbbVie Recent Developments
- 4.6 Amgen
- 4.6.1 Amgen Company Information
- 4.6.2 Amgen Business Overview
- 4.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Amgen Antibody Product Portfolio
- 4.6.5 Amgen Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Antibody Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Antibody Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 Lilly
- 4.9.1 Lilly Company Information
- 4.9.2 Lilly Business Overview
- 4.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lilly Antibody Product Portfolio
- 4.9.5 Lilly Recent Developments
- 4.10 Bristol-Myers Squibb
- 4.10.1 Bristol-Myers Squibb Company Information
- 4.10.2 Bristol-Myers Squibb Business Overview
- 4.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol-Myers Squibb Antibody Product Portfolio
- 4.10.5 Bristol-Myers Squibb Recent Developments
- 4.11 GlaxoSmithKline
- 4.11.1 GlaxoSmithKline Company Information
- 4.11.2 GlaxoSmithKline Business Overview
- 4.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 GlaxoSmithKline Antibody Product Portfolio
- 4.11.5 GlaxoSmithKline Recent Developments
- 4.12 Biogen
- 4.12.1 Biogen Company Information
- 4.12.2 Biogen Business Overview
- 4.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Biogen Antibody Product Portfolio
- 4.12.5 Biogen Recent Developments
- 4.13 AstraZeneca
- 4.13.1 AstraZeneca Company Information
- 4.13.2 AstraZeneca Business Overview
- 4.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AstraZeneca Antibody Product Portfolio
- 4.13.5 AstraZeneca Recent Developments
- 4.14 Sanofi
- 4.14.1 Sanofi Company Information
- 4.14.2 Sanofi Business Overview
- 4.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Sanofi Antibody Product Portfolio
- 4.14.5 Sanofi Recent Developments
- 4.15 Alexion Pharmaceuticals
- 4.15.1 Alexion Pharmaceuticals Company Information
- 4.15.2 Alexion Pharmaceuticals Business Overview
- 4.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
- 4.15.5 Alexion Pharmaceuticals Recent Developments
- 4.16 Seattle Genetics
- 4.16.1 Seattle Genetics Company Information
- 4.16.2 Seattle Genetics Business Overview
- 4.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Seattle Genetics Antibody Product Portfolio
- 4.16.5 Seattle Genetics Recent Developments
5 Global Antibody Market Scenario by Region
- 5.1 Global Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antibody Sales by Region: 2021-2032
- 5.2.1 Global Antibody Sales by Region: 2021-2026
- 5.2.2 Global Antibody Sales by Region: 2027-2032
- 5.3 Global Antibody Revenue by Region: 2021-2032
- 5.3.1 Global Antibody Revenue by Region: 2021-2026
- 5.3.2 Global Antibody Revenue by Region: 2027-2032
- 5.4 North America Antibody Market Facts & Figures by Country
- 5.4.1 North America Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antibody Sales by Country (2021-2032)
- 5.4.3 North America Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antibody Market Facts & Figures by Country
- 5.5.1 Europe Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antibody Sales by Country (2021-2032)
- 5.5.3 Europe Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antibody Market Facts & Figures by Country
- 5.7.1 South America Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antibody Sales by Country (2021-2032)
- 5.7.3 South America Antibody Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antibody Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antibody Sales by Type (2021-2032)
- 6.1.1 Global Antibody Sales by Type (2021-2032) & (KG)
- 6.1.2 Global Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global Antibody Revenue by Type (2021-2032)
- 6.2.1 Global Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antibody Sales by Application (2021-2032)
- 7.1.1 Global Antibody Sales by Application (2021-2032) & (KG)
- 7.1.2 Global Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global Antibody Revenue by Application (2021-2032)
- 7.2.1 Global Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antibody Value Chain Analysis
- 8.1.1 Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antibody Production Mode & Process
- 8.2 Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antibody Distributors
- 8.2.3 Antibody Customers
9 Global Antibody Analyzing Market Dynamics
- 9.1 Antibody Industry Trends
- 9.2 Antibody Industry Drivers
- 9.3 Antibody Industry Opportunities and Challenges
- 9.4 Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst